← Eichor
Condition: Myotonic Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Myotonic Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disorders
Phase N/A · 1 location(s) · Lupin Ltd. · NCT07154654Long-Term Development of Muscular Dystrophy Outcome Assessments
Phase N/A · 1 location(s) · Virginia Commonwealth University · NCT05989620Remote Assessments and Genetic Determinants of Myotonic Dystrophy
Phase N/A · 1 location(s) · University of Rochester · NCT07505342A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Ge
Phase 1/Phase 2 · 9 location(s) · Sanofi · NCT06844214Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambu
Phase 3 · 1 location(s) · Dyne Therapeutics · NCT07608432The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
Phase 3 · 7 location(s) · Lupin Ltd. · NCT06523400Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
NA · 8 location(s) · Centre Hospitalier Universitaire de Liege · NCT05982119Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Phase N/A · 1 location(s) · Cure CMD · NCT01403402Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT07415837Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dys
Phase N/A · 1 location(s) · Ain Shams University · NCT07138963A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Phase 1/Phase 2 · 26 location(s) · Vertex Pharmaceuticals Incorporated · NCT06185764A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Phase 2 · 12 location(s) · PepGen Inc · NCT06667453Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06833489Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
Phase 1/Phase 2 · 11 location(s) · Arrowhead Pharmaceuticals · NCT06138743Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
Phase N/A · 1 location(s) · Virginia Commonwealth University · NCT06747884Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844Study of ATX-01 in Participants With DM1
Phase 1/Phase 2 · 12 location(s) · ARTHEx Biotech S.L. · NCT06300307Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
Phase N/A · 1 location(s) · University of Rochester · NCT07630389Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dys
Phase 1/Phase 2 · 20 location(s) · Dyne Therapeutics · NCT05481879Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
Phase N/A · 1 location(s) · Virginia Commonwealth University · NCT07700225A Natural History Study of RYR1-Related Disorders
Phase N/A · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT06287762Molecular and Genetic Studies of Congenital Myopathies
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT00272883Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT07362875The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
Phase N/A · 2 location(s) · Radboud University Medical Center · NCT06157268Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular D
NA · 1 location(s) · Institut de Myologie, France · NCT07321977Pelvic Floor Muscle Training for Women with Myotonic Dystrophy
NA · 1 location(s) · Université de Sherbrooke · NCT06316778Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05532813Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Phase 3 · 21 location(s) · Dyne Therapeutics · NCT07486934
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.